Tarsus Pharmaceuticals (TARS) Debt Ratio (2022 - 2026)

Tarsus Pharmaceuticals' Debt Ratio history runs 5 years deep, the most recent figure standing at 0.12 for Q1 2026.

• In Q1 2026, Debt Ratio fell 13.1% year-over-year to 0.12; the TTM figure through Mar 2026 stood at 0.12 (down 13.1% YoY), while the FY2025 annual figure was 0.13, down 32.39% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.12, down from 0.13 in the prior quarter.
• The five-year high for Debt Ratio was 0.19 in Q4 2024, with the low at 0.08 in Q2 2022.
• The 5-year median for Debt Ratio is 0.12 (2026), against an average of 0.13.
• The sharpest annual moves came in 2024 and 2025: Debt Ratio jumped 72.12% in 2024, then slumped 32.39% in 2025.
• Tarsus Pharmaceuticals' Debt Ratio stood at 0.09 in 2022, then jumped by 31.69% to 0.11 in 2023, then surged by 69.68% to 0.19 in 2024, then plunged by 32.39% to 0.13 in 2025, then fell by 3.05% to 0.12 in 2026.
• Business Quant data shows TARS's Debt Ratio at 0.12 in Q1 2026, 0.13 in Q4 2025, and 0.14 in Q3 2025.